JUNS
JUNS
NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

$2.20
+0.07 (+3.29%)
As of Nov 7, 2:44 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,896.8% upside
Low Target $31.75
Average Target $43.93
High Target $69.04
Current Price $2.20
Current
$2.20
Target
$43.93
$31.75 $43.93 avg $69.04
Scenario Analysis
Bear Case
$31.75
1,343.2%
Low target
Base Case
$43.93
+1,896.8%
Avg target
Bull Case
$69.04
+3,038.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$103.50
-97.9% from high
52-Week Low
$2.05
+7.3% from low
Target vs 52W High
$43.93
-57.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%